Patients with uAID showed a trend for a higher age at onset (56.2% after age 18 years) indicating a milder phenotype in the absence of a pathogenic genotype.
← all excerpts
Clinical presentation and genetic variants in patients with autoinflammatory diseases: results from the German GARROD registry.
1
—
—